The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project

Objective: The short-term safety of methylphenidate (MPH) has been widely demonstrated; however the long-term safety is less clear. The aim of this study was to investigate the safety of MPH in relation to pubertal maturation and to explore the monitoring of bone age. Method: Participants from ADDUC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of attention disorders 2024-03, Vol.28 (5), p.722-739
Hauptverfasser: Carucci, Sara, Zuddas, Alessandro, Lampis, Angelico, Man, Kenneth K. C., Balia, Carla, Buitelaar, Jan, Danckaerts, Marina, Dittmann, Ralf W., Donno, Federica, Falissard, Bruno, Gagliano, Antonella, Garas, Peter, Häge, Alexander, Hollis, Chris, Inglis, Sarah K., Konrad, Kerstin, Kovshoff, Hanna, Liddle, Elizabeth, McCarthy, Suzanne, Neubert, Antje, Nagy, Peter, Rosenthal, Eric, Sonuga-Barke, Edmund J. S., Wong, Ian C. K., Banaschewski, Tobias, Coghill, David
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 739
container_issue 5
container_start_page 722
container_title Journal of attention disorders
container_volume 28
creator Carucci, Sara
Zuddas, Alessandro
Lampis, Angelico
Man, Kenneth K. C.
Balia, Carla
Buitelaar, Jan
Danckaerts, Marina
Dittmann, Ralf W.
Donno, Federica
Falissard, Bruno
Gagliano, Antonella
Garas, Peter
Häge, Alexander
Hollis, Chris
Inglis, Sarah K.
Konrad, Kerstin
Kovshoff, Hanna
Liddle, Elizabeth
McCarthy, Suzanne
Neubert, Antje
Nagy, Peter
Rosenthal, Eric
Sonuga-Barke, Edmund J. S.
Wong, Ian C. K.
Banaschewski, Tobias
Coghill, David
description Objective: The short-term safety of methylphenidate (MPH) has been widely demonstrated; however the long-term safety is less clear. The aim of this study was to investigate the safety of MPH in relation to pubertal maturation and to explore the monitoring of bone age. Method: Participants from ADDUCE, a two-year observational longitudinal study with three parallel cohorts (MPH group, no-MPH group, and a non-ADHD control group), were compared with respect to Tanner staging. An Italian subsample of medicated-ADHD was further assessed by the monitoring of bone age. Results: The medicated and unmedicated ADHD groups did not differ in Tanner stages indicating no higher risk of sexual maturational delay in the MPH-treated patients. The medicated subsample monitored for bone age showed a slight acceleration of the bone maturation after 24 months, however their predicted adult height remained stable. Conclusion: Our results do not suggest safety concerns on long-term treatment with MPH in relation to pubertal maturation and growth.
doi_str_mv 10.1177/10870547241226726
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2928240316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_10870547241226726</sage_id><sourcerecordid>2928240316</sourcerecordid><originalsourceid>FETCH-LOGICAL-c292t-75e928f79853ecc46422e5c828202c2ec8102a4a1ba8ebd26d6fa4b9e3b51a2b3</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxi0EoqXlAbggH8shrT1JbC-3dLP9I7VqhbrnyHEmu1kl9mI7h74PD4rLFi5IPc1o5vd9o9FHyBfOzjmX8oIzJVlZSCg4gJAg3pFjXpYy41CI96lP--wFOCKfQtgxlksp4SM5ylUuhOLimPx62iK9nfbaROp6eo9x-zzut2iHTkekztLHuUUf9UjvdZy9jkOaadvRS2eRVhukg6VVfVPT5XYYO4-HbdW5EYNBG8N3-gPDPMZAe-8mGtPBP3zt502g64BJ6Z0dDF31PZrEnVV1vV6uvtFH73Zpcko-9HoM-Pm1npD11eppeZPdPVzfLqu7zMACYiZLXIDq5UKVORpTiAIAS6NAAQMDaBRnoAvNW62w7UB0otdFu8C8LbmGNj8hZwffvXc_ZwyxmYb0wzhqi24OTbqioGA5FwnlB9R4F4LHvtn7YdL-ueGseQmn-S-cpPn6aj-3E3b_FH_TSMD5AQh6g83Ozd6md99w_A3yq5YO</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2928240316</pqid></control><display><type>article</type><title>The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project</title><source>SAGE Complete A-Z List</source><creator>Carucci, Sara ; Zuddas, Alessandro ; Lampis, Angelico ; Man, Kenneth K. C. ; Balia, Carla ; Buitelaar, Jan ; Danckaerts, Marina ; Dittmann, Ralf W. ; Donno, Federica ; Falissard, Bruno ; Gagliano, Antonella ; Garas, Peter ; Häge, Alexander ; Hollis, Chris ; Inglis, Sarah K. ; Konrad, Kerstin ; Kovshoff, Hanna ; Liddle, Elizabeth ; McCarthy, Suzanne ; Neubert, Antje ; Nagy, Peter ; Rosenthal, Eric ; Sonuga-Barke, Edmund J. S. ; Wong, Ian C. K. ; Banaschewski, Tobias ; Coghill, David</creator><creatorcontrib>Carucci, Sara ; Zuddas, Alessandro ; Lampis, Angelico ; Man, Kenneth K. C. ; Balia, Carla ; Buitelaar, Jan ; Danckaerts, Marina ; Dittmann, Ralf W. ; Donno, Federica ; Falissard, Bruno ; Gagliano, Antonella ; Garas, Peter ; Häge, Alexander ; Hollis, Chris ; Inglis, Sarah K. ; Konrad, Kerstin ; Kovshoff, Hanna ; Liddle, Elizabeth ; McCarthy, Suzanne ; Neubert, Antje ; Nagy, Peter ; Rosenthal, Eric ; Sonuga-Barke, Edmund J. S. ; Wong, Ian C. K. ; Banaschewski, Tobias ; Coghill, David</creatorcontrib><description>Objective: The short-term safety of methylphenidate (MPH) has been widely demonstrated; however the long-term safety is less clear. The aim of this study was to investigate the safety of MPH in relation to pubertal maturation and to explore the monitoring of bone age. Method: Participants from ADDUCE, a two-year observational longitudinal study with three parallel cohorts (MPH group, no-MPH group, and a non-ADHD control group), were compared with respect to Tanner staging. An Italian subsample of medicated-ADHD was further assessed by the monitoring of bone age. Results: The medicated and unmedicated ADHD groups did not differ in Tanner stages indicating no higher risk of sexual maturational delay in the MPH-treated patients. The medicated subsample monitored for bone age showed a slight acceleration of the bone maturation after 24 months, however their predicted adult height remained stable. Conclusion: Our results do not suggest safety concerns on long-term treatment with MPH in relation to pubertal maturation and growth.</description><identifier>ISSN: 1087-0547</identifier><identifier>EISSN: 1557-1246</identifier><identifier>DOI: 10.1177/10870547241226726</identifier><identifier>PMID: 38366816</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><ispartof>Journal of attention disorders, 2024-03, Vol.28 (5), p.722-739</ispartof><rights>The Author(s) 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c292t-75e928f79853ecc46422e5c828202c2ec8102a4a1ba8ebd26d6fa4b9e3b51a2b3</cites><orcidid>0000-0001-5776-5555</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/10870547241226726$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/10870547241226726$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38366816$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carucci, Sara</creatorcontrib><creatorcontrib>Zuddas, Alessandro</creatorcontrib><creatorcontrib>Lampis, Angelico</creatorcontrib><creatorcontrib>Man, Kenneth K. C.</creatorcontrib><creatorcontrib>Balia, Carla</creatorcontrib><creatorcontrib>Buitelaar, Jan</creatorcontrib><creatorcontrib>Danckaerts, Marina</creatorcontrib><creatorcontrib>Dittmann, Ralf W.</creatorcontrib><creatorcontrib>Donno, Federica</creatorcontrib><creatorcontrib>Falissard, Bruno</creatorcontrib><creatorcontrib>Gagliano, Antonella</creatorcontrib><creatorcontrib>Garas, Peter</creatorcontrib><creatorcontrib>Häge, Alexander</creatorcontrib><creatorcontrib>Hollis, Chris</creatorcontrib><creatorcontrib>Inglis, Sarah K.</creatorcontrib><creatorcontrib>Konrad, Kerstin</creatorcontrib><creatorcontrib>Kovshoff, Hanna</creatorcontrib><creatorcontrib>Liddle, Elizabeth</creatorcontrib><creatorcontrib>McCarthy, Suzanne</creatorcontrib><creatorcontrib>Neubert, Antje</creatorcontrib><creatorcontrib>Nagy, Peter</creatorcontrib><creatorcontrib>Rosenthal, Eric</creatorcontrib><creatorcontrib>Sonuga-Barke, Edmund J. S.</creatorcontrib><creatorcontrib>Wong, Ian C. K.</creatorcontrib><creatorcontrib>Banaschewski, Tobias</creatorcontrib><creatorcontrib>Coghill, David</creatorcontrib><title>The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project</title><title>Journal of attention disorders</title><addtitle>J Atten Disord</addtitle><description>Objective: The short-term safety of methylphenidate (MPH) has been widely demonstrated; however the long-term safety is less clear. The aim of this study was to investigate the safety of MPH in relation to pubertal maturation and to explore the monitoring of bone age. Method: Participants from ADDUCE, a two-year observational longitudinal study with three parallel cohorts (MPH group, no-MPH group, and a non-ADHD control group), were compared with respect to Tanner staging. An Italian subsample of medicated-ADHD was further assessed by the monitoring of bone age. Results: The medicated and unmedicated ADHD groups did not differ in Tanner stages indicating no higher risk of sexual maturational delay in the MPH-treated patients. The medicated subsample monitored for bone age showed a slight acceleration of the bone maturation after 24 months, however their predicted adult height remained stable. Conclusion: Our results do not suggest safety concerns on long-term treatment with MPH in relation to pubertal maturation and growth.</description><issn>1087-0547</issn><issn>1557-1246</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQxi0EoqXlAbggH8shrT1JbC-3dLP9I7VqhbrnyHEmu1kl9mI7h74PD4rLFi5IPc1o5vd9o9FHyBfOzjmX8oIzJVlZSCg4gJAg3pFjXpYy41CI96lP--wFOCKfQtgxlksp4SM5ylUuhOLimPx62iK9nfbaROp6eo9x-zzut2iHTkekztLHuUUf9UjvdZy9jkOaadvRS2eRVhukg6VVfVPT5XYYO4-HbdW5EYNBG8N3-gPDPMZAe-8mGtPBP3zt502g64BJ6Z0dDF31PZrEnVV1vV6uvtFH73Zpcko-9HoM-Pm1npD11eppeZPdPVzfLqu7zMACYiZLXIDq5UKVORpTiAIAS6NAAQMDaBRnoAvNW62w7UB0otdFu8C8LbmGNj8hZwffvXc_ZwyxmYb0wzhqi24OTbqioGA5FwnlB9R4F4LHvtn7YdL-ueGseQmn-S-cpPn6aj-3E3b_FH_TSMD5AQh6g83Ozd6md99w_A3yq5YO</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Carucci, Sara</creator><creator>Zuddas, Alessandro</creator><creator>Lampis, Angelico</creator><creator>Man, Kenneth K. C.</creator><creator>Balia, Carla</creator><creator>Buitelaar, Jan</creator><creator>Danckaerts, Marina</creator><creator>Dittmann, Ralf W.</creator><creator>Donno, Federica</creator><creator>Falissard, Bruno</creator><creator>Gagliano, Antonella</creator><creator>Garas, Peter</creator><creator>Häge, Alexander</creator><creator>Hollis, Chris</creator><creator>Inglis, Sarah K.</creator><creator>Konrad, Kerstin</creator><creator>Kovshoff, Hanna</creator><creator>Liddle, Elizabeth</creator><creator>McCarthy, Suzanne</creator><creator>Neubert, Antje</creator><creator>Nagy, Peter</creator><creator>Rosenthal, Eric</creator><creator>Sonuga-Barke, Edmund J. S.</creator><creator>Wong, Ian C. K.</creator><creator>Banaschewski, Tobias</creator><creator>Coghill, David</creator><general>SAGE Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5776-5555</orcidid></search><sort><creationdate>202403</creationdate><title>The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project</title><author>Carucci, Sara ; Zuddas, Alessandro ; Lampis, Angelico ; Man, Kenneth K. C. ; Balia, Carla ; Buitelaar, Jan ; Danckaerts, Marina ; Dittmann, Ralf W. ; Donno, Federica ; Falissard, Bruno ; Gagliano, Antonella ; Garas, Peter ; Häge, Alexander ; Hollis, Chris ; Inglis, Sarah K. ; Konrad, Kerstin ; Kovshoff, Hanna ; Liddle, Elizabeth ; McCarthy, Suzanne ; Neubert, Antje ; Nagy, Peter ; Rosenthal, Eric ; Sonuga-Barke, Edmund J. S. ; Wong, Ian C. K. ; Banaschewski, Tobias ; Coghill, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c292t-75e928f79853ecc46422e5c828202c2ec8102a4a1ba8ebd26d6fa4b9e3b51a2b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carucci, Sara</creatorcontrib><creatorcontrib>Zuddas, Alessandro</creatorcontrib><creatorcontrib>Lampis, Angelico</creatorcontrib><creatorcontrib>Man, Kenneth K. C.</creatorcontrib><creatorcontrib>Balia, Carla</creatorcontrib><creatorcontrib>Buitelaar, Jan</creatorcontrib><creatorcontrib>Danckaerts, Marina</creatorcontrib><creatorcontrib>Dittmann, Ralf W.</creatorcontrib><creatorcontrib>Donno, Federica</creatorcontrib><creatorcontrib>Falissard, Bruno</creatorcontrib><creatorcontrib>Gagliano, Antonella</creatorcontrib><creatorcontrib>Garas, Peter</creatorcontrib><creatorcontrib>Häge, Alexander</creatorcontrib><creatorcontrib>Hollis, Chris</creatorcontrib><creatorcontrib>Inglis, Sarah K.</creatorcontrib><creatorcontrib>Konrad, Kerstin</creatorcontrib><creatorcontrib>Kovshoff, Hanna</creatorcontrib><creatorcontrib>Liddle, Elizabeth</creatorcontrib><creatorcontrib>McCarthy, Suzanne</creatorcontrib><creatorcontrib>Neubert, Antje</creatorcontrib><creatorcontrib>Nagy, Peter</creatorcontrib><creatorcontrib>Rosenthal, Eric</creatorcontrib><creatorcontrib>Sonuga-Barke, Edmund J. S.</creatorcontrib><creatorcontrib>Wong, Ian C. K.</creatorcontrib><creatorcontrib>Banaschewski, Tobias</creatorcontrib><creatorcontrib>Coghill, David</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of attention disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carucci, Sara</au><au>Zuddas, Alessandro</au><au>Lampis, Angelico</au><au>Man, Kenneth K. C.</au><au>Balia, Carla</au><au>Buitelaar, Jan</au><au>Danckaerts, Marina</au><au>Dittmann, Ralf W.</au><au>Donno, Federica</au><au>Falissard, Bruno</au><au>Gagliano, Antonella</au><au>Garas, Peter</au><au>Häge, Alexander</au><au>Hollis, Chris</au><au>Inglis, Sarah K.</au><au>Konrad, Kerstin</au><au>Kovshoff, Hanna</au><au>Liddle, Elizabeth</au><au>McCarthy, Suzanne</au><au>Neubert, Antje</au><au>Nagy, Peter</au><au>Rosenthal, Eric</au><au>Sonuga-Barke, Edmund J. S.</au><au>Wong, Ian C. K.</au><au>Banaschewski, Tobias</au><au>Coghill, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project</atitle><jtitle>Journal of attention disorders</jtitle><addtitle>J Atten Disord</addtitle><date>2024-03</date><risdate>2024</risdate><volume>28</volume><issue>5</issue><spage>722</spage><epage>739</epage><pages>722-739</pages><issn>1087-0547</issn><eissn>1557-1246</eissn><abstract>Objective: The short-term safety of methylphenidate (MPH) has been widely demonstrated; however the long-term safety is less clear. The aim of this study was to investigate the safety of MPH in relation to pubertal maturation and to explore the monitoring of bone age. Method: Participants from ADDUCE, a two-year observational longitudinal study with three parallel cohorts (MPH group, no-MPH group, and a non-ADHD control group), were compared with respect to Tanner staging. An Italian subsample of medicated-ADHD was further assessed by the monitoring of bone age. Results: The medicated and unmedicated ADHD groups did not differ in Tanner stages indicating no higher risk of sexual maturational delay in the MPH-treated patients. The medicated subsample monitored for bone age showed a slight acceleration of the bone maturation after 24 months, however their predicted adult height remained stable. Conclusion: Our results do not suggest safety concerns on long-term treatment with MPH in relation to pubertal maturation and growth.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>38366816</pmid><doi>10.1177/10870547241226726</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0001-5776-5555</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1087-0547
ispartof Journal of attention disorders, 2024-03, Vol.28 (5), p.722-739
issn 1087-0547
1557-1246
language eng
recordid cdi_proquest_miscellaneous_2928240316
source SAGE Complete A-Z List
title The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T02%3A50%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Impact%20of%20Methylphenidate%20on%20Pubertal%20Maturation%20and%20Bone%20Age%20in%20ADHD%20Children%20and%20Adolescents:%20Results%20from%20the%20ADHD%20Drugs%20Use%20Chronic%20Effects%20(ADDUCE)%20Project&rft.jtitle=Journal%20of%20attention%20disorders&rft.au=Carucci,%20Sara&rft.date=2024-03&rft.volume=28&rft.issue=5&rft.spage=722&rft.epage=739&rft.pages=722-739&rft.issn=1087-0547&rft.eissn=1557-1246&rft_id=info:doi/10.1177/10870547241226726&rft_dat=%3Cproquest_cross%3E2928240316%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2928240316&rft_id=info:pmid/38366816&rft_sage_id=10.1177_10870547241226726&rfr_iscdi=true